Earn £1,250 RFMS Trials (Relapsing Forms of Multiple Sclerosis)

Richmond Pharmacology Ltd

clinical trials unit, clinical trial london

Are you affected by Relapsing Forms of Multiple Sclerosis?

 

We are carrying out an important clinical trial of a new treatment for people with RFMS. This is a validation study to check that a particular imaging technique works.
There are no expected benefits to you from participation in this study, it is purely for research purposes. However, by taking part in this study, you may be helping future patients by contributing to medical knowledge about RFMS.

 

To be eligible for this trial you need to be:

 

Aged 18-60
Diagnosed with relapsing-remitting MS (RRMS) or relapsing secondary progressive MS (SPMS), known as relapsing forms of MS (RFMS).
Registered with a GP who will be informed of your participation
**Please note the following criteria regarding medication

 

You cannot be included in this study if you have taken or had any of the following medications or procedures within the 6 months before the start of the study:

o Natalizumab

o Rituximab

o Daclizumab

o Cyclosporine

o Azathioprine

o Methotrexate

o Mycophenolate mofetil

o Intravenous immunoglobulin (IVIg)

o Plasmapheresis or cytapheresis

You cannot be included in this study if you have taken or had any of the following medications within the 30 days before the start of the study:

o Fingolimod

o IV corticosteroid treatment

o Oral corticosteroid treatment

o Glatiramer acetate

o Dimethyl fumarate

o Teriflunomide

o Beta-interferon

A list of other criteria will be applied by the study doctor to assess your eligibility for the study.

 

 

Study participation
Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) and Computed Tomography (CT) scans will be taken at various times. The PET and CT scans will be collected by a single instrument during the same imaging session and henceforth this procedure will be called PET scan in this form.

If you are included in this study you will have approximately 4 outpatients visits to the study site or imaging center.

Your participation will last approximately 7 weeks.
Study compensation
In recognition of your time involved in this study you will receive £1,250 and all your travel needs will be organised by us.
Speak to our Volunteer Recruitment team
If you are interested in finding out more Click here to register

Email volunteer@richmondpharmacology.com for details

Or call us weekdays between 09h00 and 17h00 on +44 (0) 208 664 5200 (choose option 1) to speak to a member of our Volunteer Recruitment team.
Ref: AE2_AUG 2015 (email / online advert / printed advert / web story text) | C15008_Advertising text_V2.0_30 09 15
This advertisement has been approved by an ethics committee and any response to this advert will be recorded but you will not be under any obligation to participate in the trial.
The contents of this advert have been approved by an ethics committee. Any response to this advertisement will be recorded.  Your response will not place you under any obligation to participate in this trial.
You may be required to remain resident in the unit until resolution of any safety issues, after which you will be discharged from the unit.

To apply for this job please visit the following URL: http://www.trials4us.co.uk/rfms-clinical-trials.php →